Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors (Q35549633)

8 August 2017

title

Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors (English)

1 reference

8 August 2017

main subject

mesenchymal stem cell

1 reference

20

Shixuan Wang

1 reference

8 August 2017

Xi Xia

1

1 reference

8 August 2017

Teng Ji

2

1 reference

8 August 2017

Pingbo Chen

3

1 reference

8 August 2017

Xiao Li

4

1 reference

8 August 2017

Yong Fang

5

1 reference

8 August 2017

Qinglei Gao

6

1 reference

8 August 2017

Shujie Liao

7

1 reference

8 August 2017

Lanying You

8

1 reference

8 August 2017

Hongbin Xu

9

1 reference

8 August 2017

Quanfu Ma

10

1 reference

8 August 2017

Peng Wu

11

1 reference

8 August 2017

Wencheng Hu

12

1 reference

8 August 2017

Mingfu Wu

13

1 reference

8 August 2017

Li Cao

14

1 reference

8 August 2017

Kezhen Li

15

1 reference

8 August 2017

Yanjie Weng

16

1 reference

8 August 2017

Zhiqiang Han

17

1 reference

8 August 2017

Junchen Wei

18

1 reference

8 August 2017

Ronghua Liu

19

1 reference

8 August 2017

Gang Xu

21

1 reference

8 August 2017

Daowen Wang

22

1 reference

8 August 2017

Jianfeng Zhou

23

1 reference

8 August 2017

Ding Ma

24

1 reference

8 August 2017

language of work or name

1 reference

3 November 2011

1 reference

8 August 2017

1 reference

8 August 2017

volume

10

1 reference

8 August 2017

page(s)

134

1 reference

Macrophage Infiltration Predicts a Poor Prognosis for Human Ewing Sarcoma

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Molecular epidemiology and its current clinical use in cancer management

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Overall survival and post-progression survival in advanced breast cancer: a review of recent randomized clinical trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

A novel oncolytic adenovirus selectively silences the expression of tumor-associated STAT3 and exhibits potent antitumoral activity

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Mesenchymal stem cell homing: the devil is in the details

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Mesenchymal stem cells in health and disease

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Primary cells as feeder cells for coculture expansion of human hematopoietic stem cells from umbilical cord blood--a comparative study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Mesenchymal stem cells: revisiting history, concepts, and assays.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Carrier cell-mediated delivery of a replication-competent adenovirus for cancer gene therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

12 July 2018

Cancer statistics, 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

MDA-MB-435 cells are derived from M14 melanoma cells--a loss for breast cancer, but a boon for melanoma research

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Selective targeting of checkpoint kinase 1 in tumor cells with a novel potent oncolytic adenovirus

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Transductional targeting of adenovirus vectors for gene therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Selective migration of neuralized embryonic stem cells to stem cell factor and media conditioned by glioma cell lines

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Oncolytic adenoviruses - selective retargeting to tumor cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Endowing human adenovirus serotype 5 vectors with fiber domains of species B greatly enhances gene transfer into human mesenchymal stem cells.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Protein transduction domains fused to virus receptors improve cellular virus uptake and enhance oncolysis by tumor-specific replicating vectors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Oncolytic viruses for the treatment of cancer: current strategies and clinical trials.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

The oncolytic virotherapy treatment platform for cancer: unique biological and biosafety points to consider

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Novel oncolytic adenovirus selectively targets tumor-associated polo-like kinase 1 and tumor cell viability

12 July 2018

1 reference

https://api.crossref.org/works/10.1186/1476-4598-10-134

Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1476-4598-10-134

Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1476-4598-10-134

Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1476-4598-10-134

Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1476-4598-10-134

Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1476-4598-10-134

Biodistribution and kinetics of the novel selective oncolytic adenovirus M1 after systemic administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1476-4598-10-134

Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1476-4598-10-134

Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

Blood clearance rates of adenovirus type 5 in mice

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3215929

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22054049

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/22054049

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22054049

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1476-4598-10-134

1 reference

Dimensions Publication ID

8 August 2017

0 references

1 reference

8 August 2017

1 reference